For many people, starting a GLP-1 medication feels like the first time their body and brain are finally working with them instead of against them. Relief!

The constant food noise quiets. Cravings decrease. Hunger feels manageable. Weight begins to shift in ways that years of dieting, tracking, restricting, and “trying harder” never seemed to accomplish. And then comes the question that almost everyone eventually asks:

“What happens if/when I stop?”

This is where the conversation often becomes oversimplified.

Ozempic…to take or not to take, that is the question. Semaglutide (marketed as Ozempic) and tirzepatide (marketed at Mounjaro and Zepbound) are peptides similar to glucagon-like peptide-1 (GLP-1) and GIP receptors. These peptide can be purchased in their pharmaceutical form (with the names above) or as compounded peptides with more ability to adjust dosage. These peptides can be used for blood glucose management, obesity management, and many other conditions. But, it’s hard to sort through the information swirling around about these peptides/medications,